International Assets Investment Management LLC Has $4.41 Million Holdings in UiPath Inc. (NYSE:PATH)

International Assets Investment Management LLC increased its position in UiPath Inc. (NYSE:PATH - Free Report) by 1,649.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 177,358 shares of the healthcare company's stock after buying an additional 167,218 shares during the quarter. International Assets Investment Management LLC's holdings in UiPath were worth $4,406,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. HighMark Wealth Management LLC purchased a new position in UiPath in the fourth quarter valued at about $27,000. FNY Investment Advisers LLC purchased a new position in UiPath in the fourth quarter valued at about $40,000. Tyler Stone Wealth Management purchased a new position in UiPath in the second quarter valued at about $28,000. FSC Wealth Advisors LLC purchased a new position in UiPath in the fourth quarter valued at about $43,000. Finally, Fifth Third Bancorp raised its position in UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company's stock valued at $34,000 after purchasing an additional 1,905 shares during the period. 62.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PATH has been the topic of several research reports. DA Davidson raised their price objective on UiPath from $20.00 to $24.00 and gave the company a "neutral" rating in a research report on Thursday, March 14th. Needham & Company LLC reissued a "buy" rating and issued a $30.00 price objective on shares of UiPath in a research report on Wednesday, March 20th. Canaccord Genuity Group raised their target price on UiPath from $27.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, March 15th. Barclays raised their target price on UiPath from $23.00 to $25.00 and gave the company an "equal weight" rating in a research note on Friday, March 15th. Finally, Mizuho raised their target price on UiPath from $22.00 to $25.00 and gave the company a "neutral" rating in a research note on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, UiPath presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.41.

UiPath Price Performance

NYSE:PATH traded down $0.29 during mid-day trading on Wednesday, reaching $19.12. The stock had a trading volume of 4,566,134 shares, compared to its average volume of 9,016,959. The company has a market capitalization of $10.88 billion, a price-to-earnings ratio of -114.17 and a beta of 0.96. UiPath Inc. has a 1-year low of $12.38 and a 1-year high of $27.87. The stock's 50 day simple moving average is $23.16 and its two-hundred day simple moving average is $21.47.

UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. Sell-side analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.66, for a total value of $866,400.00. Following the completion of the transaction, the chief financial officer now directly owns 660,762 shares in the company, valued at $14,312,104.92. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders sold a total of 72,000 shares of company stock worth $1,591,360 over the last ninety days. Company insiders own 31.03% of the company's stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.